ReWalk Robotics Ltd. - ADR

Name: ReWalk Robotics Ltd. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: ReWalk Robotics Ltd. - ADR

Stock Card

$0.97

$-5.80 (-85.69%)

As on 01-Mar-2024 09:30EDT

Market cap

$62 Mln

Revenue (TTM)

$14 Mln

P/E Ratio

P/B Ratio

1.1

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

ReWalk Robotics - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.92 High: 0.98

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-9 Mln
ROE

-0.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-1.3
Debt to Equity

0
Book Value

$0
EPS

$0
Face value

--
Shares outstanding

59,480,100

10 Years Aggregate

CFO

$-182.74 Mln

EBITDA

$-195.10 Mln

Net Profit

$-185.34 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
ReWalk Robotics - ADR	-82.2	-86.8	-81.3	-81.1	-62.6	-53.4	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8

As on 01-Mar-2024 | *As on 28-Aug-2026

Company	2023	2022	2021	2020	2019	2018	2017
ReWalk Robotics - ADR	2.4	-38.2	-6.8	-38.9	-50.4	-84.0	-60.7
BSE Sensex	18.7	4.4	22.0	15.8	14.4	5.9	27.9
BSE Sensex	18.7	4.4	22.0	15.8	14.4	5.9	27.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About ReWalk Robotics - ADR

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company... offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Read more

CEO & Director

Mr. Lawrence J. Jasinski BS, MBA
CEO & Director

Mr. Lawrence J. Jasinski BS, MBA
Headquarters

Yokneam Illit
Website

https://www.rewalk.com

FAQs for ReWalk Robotics - ADR

What is the current share price of ReWalk Robotics Ltd - ADR Today?

The share price of ReWalk Robotics Ltd - ADR is $0.97 (NASDAQ) as of 01-Mar-2024 09:30 EDT. ReWalk Robotics Ltd - ADR has given a return of -62.63% in the last 3 years.

What is the current PB & PE ratio of ReWalk Robotics Ltd - ADR?

Since, TTM earnings of ReWalk Robotics Ltd - ADR is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2023	31,843.13	1,004.38
2022	-2.40	0.69
2021	-6.03	0.86
2020	-2.10	1.25
2019	-1.44	2.08

What is the 52 Week High and Low of ReWalk Robotics Ltd - ADR?

The 52-week high and low of ReWalk Robotics Ltd - ADR are Rs -- and Rs -- as of 30-Aug-2026.

What is the market cap of ReWalk Robotics Ltd - ADR?

ReWalk Robotics Ltd - ADR has a market capitalisation of $ 62 Mln as on 01-Mar-2024. As per SEBI classification, it is a company.

Should I invest in ReWalk Robotics Ltd - ADR?

Before investing in ReWalk Robotics Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.